Vaginal Brachytherapy Effective for Endometrial Cancer (03-17-2010)

Among women who have undergone surgery for high-intermediate risk endometrial cancer, vaginal brachytherapy is as effective as pelvic external beam radiotherapy in the prevention of vaginal recurrence and produces fewer side effects. These results... Continue Reading

Neratinib Active in Women with Advanced HER2-positive Breast Cancer (03-16-2010)

Among women with advanced HER2-positive breast cancer, the investigational drug neratinib produced promising response rates and progression-free survival. The results of this Phase II clinical trial were published in the Journal of Clinical Oncology. Twenty... Continue Reading

Children and Teens Have Better NHL Survival than Young Adults (03-15-2010)

Even after accounting for stage at diagnosis and subtype of non-Hodgkin’s lymphoma (NHL), children and teens with NHL have better survival than young adults with NHL. These results were published in the Archives of Pediatrics and Adolescent Medicine. Non-Hodgkin’s... Continue Reading

Radiofrequency Ablation Effective For Small Kidney Cancers (03-12-2010)

Radiofrequency ablation appears to be an effective treatment for patients with small kidney cancers. These results were presented at the 2010 ASCO Genitourinary Cancers Symposium. The kidneys are each filled with tiny tubules that clean and filter ... Continue Reading

Test Available for Pre-surgical Evaluation of Ovarian Mass (03-11-2010)

For women who require surgery for an ovarian mass, the OVA1™ test may help identify the most appropriate type of surgeon. The test assesses the likelihood that cancer is present; when cancer is likely, surgery may best be performed by a gynecologic... Continue Reading

Obesity Linked with Worse Colon Cancer Outcomes (03-10-2010)

Compared with healthy-weight patients, obese colon cancer patients have a higher risk of cancer recurrence and death. These results were published in Clinical Cancer Research. Obesity is increasingly being recognized as a risk factor not only for cancer... Continue Reading

Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex (03-9-2010)

Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant cancer recurrence in both node-negative and node-positive... Continue Reading

Addition of Hormone Therapy to Radiation Improves Survival in Intermediate-risk, Early-stage Prostate Cancer (03-9-2010)

Short-term hormone therapy delivered before and during moderate-dose radiation therapy improves survival and reduces risk of recurrence compared with radiation alone in men with intermediate-risk, early-stage prostate cancer. The results of this Phase... Continue Reading

Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer (03-9-2010)

The addition of a urine test to standard cystoscopy screening in order to monitor for bladder cancer recurrence unnecessarily increases the cost of monitoring as well as the risk for a false-positive result and does not improve tumor detection, according... Continue Reading

PCA3 Test May Help Guide Prostate Biopsy Decisions (03-8-2010)

The PCA3 urine test may help guide decisions about the need for repeat prostate biopsy in men with a negative initial biopsy but elevated PSA. These results were presented at the 2010 ASCO Genitourinary Cancer Symposium. Since the late 1980s, the primary... Continue Reading

Bisphosphonates May Reduce the Risk of Breast Cancer (03-8-2010)

Use of bisphosphonates to treat osteoporosis may reduce the risk of breast cancer. The results of this study were published in the British Journal of Cancer. Bisphosphonates are a class of drugs used to prevent and treat osteoporosis and to reduce... Continue Reading

Cabazitaxel Shows Promise in Advanced Prostate Cancer (03-5-2010)

Among men with metastatic, hormone refractory prostate cancer that has progressed after Taxotere® (docetaxel)-based chemotherapy, the investigational chemotherapy drug cabazitaxel may improve survival. The results of this Phase III clinical trial... Continue Reading